• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NUC
Click for more information
0.00% 15.0¢

NUCHEV LIMITED - News & Media

Market Cap $21.95M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Packaged Foods

Nuchev Limited is an Australia-based health and nutrition solutions company. The Company... Nuchev Limited is an Australia-based health and nutrition solutions company. The Company operates globally oriented food business, which is focused on developing, marketing, and selling a range of premium Australian-made nutritional and digestive products. The Company's primary products include its Oli6 branded goat infant formula and nutritional range, which are sold across multiple sales channels in Australia and China. The Company's product categories include Oli6 Infant and Follow-on Formula, and Oli6 Adult Milk Powder. It sells goat formula, nutritional powders and related products to wholesale customers and end consumers. The Company sells its products across multiple off-line and on-line channels in China, Australia and New Zealand markets.More

No News & Media currently available.

(20min delay)
Last
15.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $21.95M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 153644 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 21829 1
View Market Depth
Last trade - 16.12pm 02/10/2024 (20 minute delay) ?
NUC (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.